Nucleic Acids Research, Vol 27, Issue 24 4725-4733, Copyright © 1999 by Oxford University Press
RR Bonala, RA Rieger, S Shibutani, AP Grollman, CR Iden and F Johnson
3,N(4)-Ethano-2'-deoxycytidine (ethano-dC) may be incorporated successfully
into synthetic oligodeoxynucleotides by omitting the capping procedure used
in the automated DNA synthetic protocols immediately after inserting the
lesion and in all iterations thereafter. Ethano-dC is sensitive to acetic
anhydride found in the capping reagent, and multiple oligomeric products
are formed. These products were identified by examining the reaction of
ethano-dC with the capping reagent, and several acetylated, ring-opened
products were characterized by electrospray mass spectrometry and collision
induced dissociation experiments on a tandem quadrupole mass spectrometer.
A scheme for the formation of the acetylated products is proposed. In
addition, the mutagenic profile of ethano-dC was re-examined and compared
to that for etheno-dC. Ethano-dC is principally a blocking lesion; however,
when encountered by the exo(-)Klenow fragment of DNA polymerase, dAMP
(22%), TMP (16%), dGMP (5.3%) and dCMP (1.2%) were all incorporated
opposite ethano-dC, along with an oligomer containing a one-base deletion
(0.6%).
ARTICLES
3,N(4)-ethano-2'-deoxycytidine: chemistry of incorporation into oligomeric DNA and reassessment of miscoding potential
Department of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, NY 11794-3400, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?